Tzu-Chi Liao

School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan, Taiwan (Republic of China)

Poster(s):

• (Q) Effect Modification by Indications to The Risks of Major Thromboembolic Adverse Events in Patients Receiving Intravitreal Anti-Vascular Endothelial Growth Factor Treatment – a Population-Based Retrospective Cohort Study
  Friday, August 26, 2022

  8:00 AM – 6:00 PM CEST

• (4) Comparative Risk of Herpes Zoster and Postherpetic Neuralgia in Patients with Psoriasis Receiving IL-17 Inhibitor and IL-12/23 Inhibitor Versus Traditional Systemic Immunosuppressants
  Sunday, August 28, 2022

  8:00 AM – 1:45 PM CEST

• (288) Evaluating The Impact of Electronic Health Record (EHR) Loss to Follow-Up Data in Patients with Atherosclerotic Cardiovascular Disease (ASCVD)
  Saturday, August 27, 2022

  8:00 AM – 6:00 PM CEST